Cranswick (CWK) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
12 Jan, 2026Executive summary
Achieved record first-half results with 6.1% revenue growth to £1,329.9m, driven by strong volume increases and market share gains in poultry and pet food.
Adjusted profit before tax rose 17.4% to £95.8m, with adjusted EPS up 17.7% to 132.1p and interim dividend up 10.1% to 25.0p per share.
Significant capital investment of £47.7m in H1, with major projects in poultry, pork, and Mediterranean foods underway.
Free cash conversion at 110.9% and net debt (pre-IFRS 16) reduced to £0.9m, supporting a progressive dividend policy.
Positive outlook for the full year, with performance in line with market expectations and ongoing investment in capacity and automation.
Financial highlights
Revenue increased by 6.1% year-over-year to £1,329.9m; like-for-like revenue up 5.8%.
Adjusted operating profit rose 16.5% to £99.6m; adjusted operating margin at 7.5% (+67bps year-over-year).
Adjusted EPS up 17.7% to 132.1p; statutory EPS up 3.8% to 124.0p.
Free cash flow grew 34.6% to £105.4m; free cash conversion at 110.9%.
Return on capital employed improved to 18.7%, up 234bps year-over-year.
Outlook and guidance
Trading remains strong entering the key Christmas period and Q3, with order books at record levels.
Full-year financial performance expected to be in line with current market expectations for adjusted profit before tax (£189.0m–£193.0m).
Ongoing focus on mitigating inflationary headwinds, especially from labor and National Insurance cost increases.
FY25 CapEx guidance reconfirmed at circa £100m, focused on capacity, capability, and automation.
Continued investment in poultry and premium categories to drive future growth.
Latest events from Cranswick
- Record Christmas trading and strong Q3 growth drive profit outlook to upper market range.CWK
Q3 2026 TU27 Jan 2026 - Double-digit revenue and profit growth, record investment, and strong outlook for the year.CWK
H1 202625 Nov 2025 - Record revenue and margin growth, strong investment, and 35 years of dividend increases.CWK
H2 202519 Nov 2025 - Revenue up 9.7% year-over-year, with strong growth and positive outlook maintained.CWK
Q1 2026 TU28 Jul 2025 - Upgraded FY25 outlook driven by strong trading, volume growth, and ongoing investment.CWK
Trading Update13 Jun 2025 - Q1 revenue up 6.7% with strong UK demand and continued investment in capacity.CWK
Q1 2025 TU13 Jun 2025 - Record Q3 growth and JSR Genetics acquisition drive supply security and efficiency.CWK
Q3 2025 TU6 Jun 2025 - Upgraded targets and major investments drive growth in premium food categories and efficiency.CWK
CMD 20256 Jun 2025